Yang PC - Search Results

1

Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and Paclitaxel as first-line treatment.

Yang CH, Chen MC, Cheng AL, Hsu CH, Yeh KH, Yu YC, Whang-Peng J, Yang PC. Yang CH, et al. Among authors: yang pc. Oncology. 2005;68(4-6):350-5. doi: 10.1159/000086974. Epub 2005 Jul 11. Oncology. 2005. PMID: 16020962 Clinical Trial.

2

Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.

Yuan A, Yu CJ, Luh KT, Kuo SH, Lee YC, Yang PC. Yuan A, et al. Among authors: yang pc. J Clin Oncol. 2002 Feb 15;20(4):900-10. doi: 10.1200/JCO.2002.20.4.900. J Clin Oncol. 2002. PMID: 11844810

3

Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis.

Wang JY, Chen KY, Wang JT, Chen JH, Lin JW, Wang HC, Lee LN, Yang PC. Wang JY, et al. Among authors: yang pc. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):735-41. doi: 10.1016/s0360-3016(02)02994-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12377325

4

Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13.

Chie WC, Yang CH, Hsu C, Yang PC. Chie WC, et al. Among authors: yang ch, yang pc. Qual Life Res. 2004 Feb;13(1):257-62. doi: 10.1023/B:QURE.0000015295.74812.06. Qual Life Res. 2004. PMID: 15058806

5

Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.

Sher YP, Shih JY, Yang PC, Roffler SR, Chu YW, Wu CW, Yu CL, Peck K. Sher YP, et al. Among authors: yang pc. Clin Cancer Res. 2005 Jan 1;11(1):173-9. Clin Cancer Res. 2005. PMID: 15671543

6

Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.

Yuan A, Yu CJ, Shun CT, Luh KT, Kuo SH, Lee YC, Yang PC. Yuan A, et al. Among authors: yang pc. Int J Cancer. 2005 Jul 1;115(4):545-55. doi: 10.1002/ijc.20898. Int J Cancer. 2005. PMID: 15704107

7

Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials.

Kuo SH, Yang CH, Yu CJ, Hsu C, Cheng AL, Yang PC. Kuo SH, et al. Among authors: yang ch, yang pc. Lung Cancer. 2005 May;48(2):275-80. doi: 10.1016/j.lungcan.2004.10.004. Epub 2004 Dec 15. Lung Cancer. 2005. PMID: 15829329

8

Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.

Chen KY, Chang CH, Yu CJ, Kuo SH, Yang PC. Chen KY, et al. Among authors: yang pc. Cancer. 2005 Jun 15;103(12):2566-74. doi: 10.1002/cncr.21087. Cancer. 2005. PMID: 15852359 Free article.

9

Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein.

Yang CH, Huang CJ, Yang CS, Chu YC, Cheng AL, Whang-Peng J, Yang PC. Yang CH, et al. Among authors: yang pc, yang cs. Cancer Res. 2005 Aug 1;65(15):6943-9. doi: 10.1158/0008-5472.CAN-05-0641. Cancer Res. 2005. PMID: 16061679

10

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer.

Shih JY, Gow CH, Yu CJ, Yang CH, Chang YL, Tsai MF, Hsu YC, Chen KY, Su WP, Yang PC. Shih JY, et al. Among authors: yang ch, yang pc. Int J Cancer. 2006 Feb 15;118(4):963-9. doi: 10.1002/ijc.21458. Int J Cancer. 2006. PMID: 16152581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,381 results

Search Page

Filters